<DOC>
	<DOCNO>NCT01836458</DOCNO>
	<brief_summary>This study aim determine Minimum Inhibitory Concentration KAE609 adult male patient acute , uncomplicated malaria due P.falciparum monoinfection single dosing KAE609</brief_summary>
	<brief_title>A Study Find Minimum Inhibitory Concentration KAE609 Adult Male Patients With P. Falciparum Monoinfection</brief_title>
	<detailed_description>There total approximately 45 patient recruit study six dos KAE609 investigated.The dose group run sequence . Patient give single dose KAE609 follow 42 day .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Key Monoinfection P. falciparum confirm microscopy Asexual P. falciparum parasitemia count 5,000 50,000/µL Axillary temperature ≥37.5 ºC oral/tympanic/rectal temperature ≥38 ºC ; similar document temperature previous 24 hour Body weight 40 90 kg Key Signs symptom severe malaria accord World Health Organization ( WHO ) 2010 criterion Mixed Plasmodium infection , i.e . infection one species malaria parasite Use investigational drug within 30 day within 5 halflives enrollment , whichever long History antimalarial use within 2 month screen Use antibiotic antimalarial activity prohibit medication within 14 day screen Long QT syndrome QTc use Fridericia 's formula &gt; 430 msec History malignancy organ system ( localize basal cell carcinoma skin ) , treat untreated , within past 5 year , regardless whether evidence local recurrence metastasis Hemoglobin level &lt; 10 g/dL Liver disease injury indicate elevated liver test SGPT ( ALT ) SGOT ( AST ) &gt; 2 time upper limit normal Renal dysfunction indicate serum creatinine &gt; 2 time upper limit normal absence dehydration ; case dehydration , serum creatinine &lt; 2 time upper limit normal oral parental rehydration Known immunocompromised ( include HIV infection ) receive immunosuppressive therapy time enrollment ; HIV testing require Known history hepatitis B C ; test require Febrile condition due disease malaria ( e.g . acute low respiratory tract infection ) , know underlie chronic severe disease ( e.g . cardiac , hepatic , renal , gastrointestinal , neurologic , psychiatric disease ) , condition preclude enrollment study accord investigator Severe vomit define &gt; 3 time previous 24 hour inability tolerate oral medication ; severe diarrhea define ≥3 watery stool previous 24 hour Severe malnutrition define body mass index ( BMI ) &lt; 18.5 kg/m2 unintentional loss weight ≥10 % evidence suboptimal intake result loss subcutaneous fat and/or severe muscle waste Active tuberculosis history take antituberculosis medication within 24 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Malaria , KAE609</keyword>
</DOC>